Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Breast 1

Conditions

Motor Activity 234Breast Neoplasms 132Neoplasms 97Prostatic Neoplasms 34Fatigue 34Obesity 24Lung Neoplasms 23Colorectal Neoplasms 22Polycystic Ovary Syndrome 17Ovarian Neoplasms 13Colonic Neoplasms 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Pancreatic Neoplasms 11Lymphoma 11Carcinoma, Non-Small-Cell Lung 11Weight Loss 10Rectal Neoplasms 10Multiple Myeloma 10Lymphedema 10Hematologic Neoplasms 10Head and Neck Neoplasms 10Leukemia 9Cardiotoxicity 9Insulin Resistance 8Brain Neoplasms 8Stomach Neoplasms 7Peripheral Nervous System Diseases 7Overweight 6Esophageal Neoplasms 6Cognitive Dysfunction 6

Interventions

Nebivolol 1Methods 1Exercise Therapy 1Exercise 1(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Ventricular Dysfunction, Left × Exercise × Clear all
NCT03850171 2023-02-27

Cancer Adverse Effects PReventIon With Care & Exercise: the CAPRICE Study

Insel Gruppe AG, University Hospital Bern

Phase NA Terminated
57 enrolled
BreastLymphoid

Breast Diseases, Breast Neoplasms, Heart Failure, Lymphoma, Motor Activity, Ventricular Dysfunction, Left, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡